EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A myosin hypertrophic cardiomyopathy mutation disrupts the super-relaxed state and boosts contractility by enhanced actin attachment

Robert C Cail iD, Bipasha Barua, Faviolla A Báez-Cruz, Donald A Winkelmann, Yale E Goldman iD, E Michael Ostap iD

Proceedings of the National Academy of Sciences · 30.12.2025 · 122 (52)

DOI: 10.1073/pnas.2521561122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 24.12.2025. Verfasst von Robert C Cail und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104. Hauptthemen laut MEDLINE: Cardiomyopathy, Hypertrophic, Actins, Mutation, Myosin Heavy Chains. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NSF | ENG | Division of Civil, Mechanical and Manufacturing Innovation (CMMI), HHS | NIH | National Institute of General Medical Sciences (NIGMS).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypertrophic cardiomyopathy (HCM) is a leading cause of cardiac failure among individuals under 35. Many genetic mutations that cause HCM seem to enhance ventricular systolic function, suggesting that these HCM mutations are hypercontractile. Among the most common causes of HCM are mutations in the gene MYH7, which encodes for β-cardiac myosin, the principal human ventricular myosin. Previous work has demonstrated that, for purified myosins, some MYH7 mutations are gain-of-function while others cause reduced function, so how they lead to enhanced contractility is not clear. Here, we have characterized the mechanics and kinetics of the severe HCM-causing mutation M493I. Motility assays demonstrate a 70% reduction of actin filament gliding velocities on M493I-coated surfaces relative to wild type (WT). This mutation slows ADP release from actomyosin•ADP fivefold without affecting phosphate release or ATP binding. Yet it enhances steady-state ATPase V max twofold. Through single-molecule mechanical studies, we find that M493I myosin has a normal working stroke of 5 nm but a significantly prolonged actin attachment duration. Under isometric feedback, M493I myosins produce high, sustained force, with an actin detachment rate that is less sensitive to force than that of WT myosin. We also report direct measurement of the equilibrium state of the super-relaxed to disordered relaxed regulatory transition and show its disruption in M493I, with a concomitant enhancement to actin attachment kinetics. Together, these data demonstrate that enhanced myosin binding from inhibition of myosin’s off state, combined with slow ADP release and enhanced force production, underlie the enhanced function and etiology of this HCM mutation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiomyopathy, HypertrophicActinsMutationMyosin Heavy ChainsMyocardial ContractionVentricular MyosinsCardiac MyosinsHumansAdenosine DiphosphateKineticsActin CytoskeletonActomyosinAdenosine Triphosphate

Stichwörter der Autor:innen

actomyosinhypertrophic myopathymyosinoptical trapsuper-relaxed state

Substanzen

ActinsMYH7 protein, humanMyosin Heavy ChainsVentricular MyosinsAdenosine DiphosphateActomyosinCardiac MyosinsAdenosine Triphosphate

Autor:innen und Institutionen

  • Department of Physiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104.
  • Pennsylvania Muscle Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104.
  • Department of Pathology and Laboratory Medicine, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ 07103.
  • Department of Pharmacology, University of California Davis, Davis, CA 95616.
  • Department of Molecular and Cell Biology, University of California Davis, Davis, CA 95616.

ORCID-Profile: Robert C Cail, Yale E Goldman, E Michael Ostap

Förderung

  • NIGMS NIH HHS
  • NSF | ENG | Division of Civil, Mechanical and Manufacturing Innovation (CMMI)
  • HHS | NIH | National Institute of General Medical Sciences (NIGMS)
  • NIAMS NIH HHS
  • NHLBI NIH HHS
  • HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)

Zitieren

APA

Cail, R. C., Barua, B., Báez-Cruz, F. A., Winkelmann, D. A., Goldman, Y. E., & Ostap, E. M. (2025). A myosin hypertrophic cardiomyopathy mutation disrupts the super-relaxed state and boosts contractility by enhanced actin attachment. Proceedings of the National Academy of Sciences, 122(52). https://doi.org/10.1073/pnas.2521561122

Vancouver

Cail RC, Barua B, Báez-Cruz FA, Winkelmann DA, Goldman YE, Ostap EM. A myosin hypertrophic cardiomyopathy mutation disrupts the super-relaxed state and boosts contractility by enhanced actin attachment. Proceedings of the National Academy of Sciences. 2025;122(52). doi:10.1073/pnas.2521561122

BibTeX
@article{Cail2025,
  author = {Cail, Robert C and Barua, Bipasha and Báez-Cruz, Faviolla A and Winkelmann, Donald A and Goldman, Yale E and Ostap, E Michael},
  title = {A myosin hypertrophic cardiomyopathy mutation disrupts the super-relaxed state and boosts contractility by enhanced actin attachment},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2025},
  volume = {122},
  number = {52},
  doi = {10.1073/pnas.2521561122}
}
Kostenlos starten →